卡斯特-DTA:用于预测药物标亲和力的等价图神经网络
Rachit Kumar1,2,3, Joseph D Romano3,4,5, Marylyn D Ritchie3,5,6
1Medical Scientist Training Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States.
Briefings in bioinformatics
|October 26, 2025
概括
新的深度学习模型CASTER-DTA通过利用3D蛋白质结构准确预测药物标结合亲和力. 该工具增强了药物设计,并提供了FDA批准的药物与人体蛋白质组相互作用的全面数据库.
科学领域:
- 计算化学是一种计算化学.
- 结构生物学是结构生物学.
- 药物发现 药物发现
背景情况:
- 准确的药物向亲和力 (DTA) 预测对于有效的药物设计和查至关重要.
- 虽然像AlphaFold这样的3D蛋白质结构预测工具是可以访问的,但可扩展的DTA预测方法通常不充分利用这种结构信息.
- 现有的方法缺乏对蛋白质结构数据的强有力的整合,以改善结合亲和力预测.
研究的目的:
- 开发一种新的深度学习框架,CASTER-DTA,有效地利用3D蛋白质结构信息来准确预测药物向亲和力.
- 通过结合蛋白质和药物成分之间的注意力机制,提高DTA预测模型的可解释性.
- 创建一个全面的资源预测结合亲和力对FDA批准的药物对人类蛋白质组.
主要方法:
- 利用等价图神经网络 (GNN) 来从3D结构中进行强大的蛋白质表示学习.
- 采用标准的GNN来学习药物的分子表示.
- 在蛋白质残留物和药物原子之间集成了一个基于注意力的机制,以捕获关键相互作用并提高可解释性.
主要成果:
- 在多个DTA预测的基准数据集中,CASTER-DTA实现了最先进的性能改进.
- 该模型为药物向相互作用提供了新的见解,证明了其实用性超出了简单的亲和力预测.
- 产生了针对人类蛋白质组的所有FDA批准的药物的结合 afinities 的大规模数据集.
结论:
- 通过有效地整合3D结构信息,CASTER-DTA在预测药物标结合亲和度方面取得了重大进展.
- 开发的模型和相关的大规模数据集为药物发现和开发提供了宝贵的资源.
- 一个公开可访问的网络服务器允许研究人员预测定制蛋白质-药物对的结合亲和关系.
更多相关视频
05:50Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
1.4K
05:47Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
1.3K
相关概念视频
01:26Targets for Drug Action: Overview
10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
01:25Drug-Receptor Bonds
4.2K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
4.2K
01:26Drug Discovery: Overview
11.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.0K
01:29Drug-Receptor Interactions
7.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K
01:28Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
01:30Quantitative Aspects of Drug-Receptor Interaction
1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K